Key result
Rituximab-based therapy achieved significant clinical improvement in a patient with localized pulmonary MALT lymphoma presenting as an atypical solitary thick-walled cystic lung lesion.
Population
A 62-year-old female diagnosed with p-MALT lymphoma presenting as a singular cystic lesion
Design
Case report
Authors
Loading...
Hypothesis-generating for rituximab in atypical cystic pulmonary MALT lymphoma; prospective validation required before broader use.
Case Report (n=1)
No
This case highlights the importance of recognizing distinctive cystic lung features in p-MALT lymphoma and the efficacy of rituximab-based therapy for localized disease.
Li et al. (2025) conducted a case report in Pulmonary MALT lymphoma (n=1). Rituximab was evaluated on Clinical improvement. Rituximab-based therapy achieved significant clinical improvement in a patient with localized pulmonary MALT lymphoma presenting as an atypical solitary thick-walled cystic lung lesion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: